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general mechanism, as other curved bacteria, such as case activity of eIF4A to the cap-proximal region of
mRNA, is essential for initiation. mRNA unwinding andHelicobacter pylori, contain similar proteins.
binding of eIF4G to the eIF3 component of the 43S
complex allow ribosomal attachment to mRNA.Joe Lutkenhaus
The activity of eIF4F is a focal point for the regulationDepartment of Microbiology, Molecular Genetics,
of protein synthesis (Gingras et al., 1999). Mammalianand Immunology
eIF4E binding proteins (4E-BPs) and yeast p20 inhibitUniversity of Kansas Medical Center
cap-dependent initiation by blocking the interaction of
Kansas City, Kansas 66160
eIF4G with eIF4E. Inhibition by 4E-BP is related to its
phosphorylation state, so that hyperphosphorylated 4E-Selected Reading
BP has the lowest affinity for eIF4E. Mammalian eIF4E
also undergoes regulated phosphorylation by the eIF4G-Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter,
P. (2002). Molecular Biology of the Cell. (New York: Garland Science). associated Mnk kinases. Phosphorylation of eIF4E is
Ausmees, N., Kuhn, J.R., and Jacobs-Wagner, C. (2003). Cell 115, increased in response to stimuli that activate translation.
this issue, 705–713. Its significance for eIF4E’s function is a topic of current
Daniel, R.A., and Errington, J. (2003). Cell 113, 767–776. interest (Scheper and Proud, 2002).
Errington, J. (2003). Nat. Cell Biol. 5, 175–178. The structures of mammalian and yeast eIF4E bound
to the cap analogs m7GDP, m7GTP, and m7GpppA areJones, L.J., Carballido-Lopez, R., and Errington, J. (2001). Cell
104, 913–922. similar (Marcotrigiano et al., 1997; Matsuo et al., 1997).
Motaleb, M.A., Corum, L., Bono, J.L., Elias, A.F., Rosa, P., Samuels, In these structures, eIF4E consists of an unstructured
D.S., and Charon, N.W. (2000). Proc. Natl. Acad. Sci. USA 97, 10899– N terminus and an antiparallel  sheet backed by three
10904. helices on its convex surface. Binding of cap analogs
Pinho, M.G., and Errington, J. (2003). Mol. Microbiol. 50, 871–881. to a hydrophobic slot on eIF4E’s concave surface is
Strelkov, S.V., Herrmann, H., and Aebi, U. (2003). Bioessays 25, stabilized by interactions that include - stacking of
243–251. the m7G base between tryptophan residues, a hydrogen-
van den Ent, F., Amos, L.A., and Lowe, J. (2001). Nature 413, 39–44. bonding network that fixes the triphosphate moiety, and
Young, K.D. (2003). Mol. Microbiol. 49, 571–580. additional interactions with the second RNA base. A
conserved Tyr-X-X-X-X-Leu-φ recognition motif (where
φ is Leu, Met, or Phe) in eIF4G binds to a phylogeneti-
cally invariant site on the convex surface of eIF4E; 4E-
BPs contain the same motif and bind to the same site
on eIF4E, thereby preventing eIF4E-eIF4G interactionCoupled Folding
(Marcotrigiano et al., 1999). 4E-BP and eIF4G peptidesduring Translation Initiation containing this recognition motif are disordered but as-
sume a helical conformation when they bind to eIF4E,
whereas the structure of eIF4E remains unaltered (Mar-
cotrigiano et al., 1999).The structure of the eukaryotic initiation factor eIF4E
Biochemical data suggested that association of eIF4Gbound to a cognate domain of eIF4G and m7GDP in
with eIF4E significantly enhances eIF4E’s affinity for thethis issue of Cell shows that these factors undergo
cap (Haghighat and Sonenberg, 1997; Ptushkina et al.,coupled folding to form a stable complex with high
1998). However, interaction of eIF4E with an eIF4G-pep-cap binding activity that promotes efficient ribosomal
tide containing this recognition motif did not enhanceattachment to mRNA during translation initiation.
eIF4E’s cap binding activity, whereas a larger yeast
eIF4G fragment containing this motif did (von der Haar
An early step in the initiation of translation on most et al., 2000). Moreover, mutations outside this motif influ-
eukaryotic mRNAs is the attachment of a 43S preinitia- enced eIF4G’s interaction with eIF4E (Hershey et al.,
tion complex, comprising a 40S ribosomal subunit, initia- 1999). The observed enhanced affinity of eIF4E for the
tor tRNA, and eukaryotic initiation factors (eIFs) 1, 1A, cap and stabilization of the interaction would signifi-
2, and 3 to the 5 end of mRNA. The complex then scans cantly increase the efficiency of attachment of 43S com-
downstream to the initiation codon. Eukaryotic mRNAs plexes to capped mRNAs.
have a 5 terminal “cap” structure (m7G[5]ppp[5]N, How the interaction between eIF4G and eIF4E led to
where N is any nucleotide) and a 3 poly(A) tail that the enhanced association of eIF4E with the cap re-
synergistically enhance ribosomal recruitment to mRNA. mained unknown. Now, Gross et al. (2003) in this issue
Ribosomal attachment begins with recognition of the of Cell report the solution structure of yeast eIF4E/cap
cap by the 25 kDa subunit (eIF4E) of the cap binding bound to eIF4G (393–490), which shows that eIF4E’s
complex eIF4F, which also contains eIF4A and eIF4G interaction with eIF4G is not limited to the recognition
subunits. eIF4G has binding sites for eIF4E, eIF4A, eIF3, motif but extends over a large (4400 A˚2) interface area.
the poly(A) binding protein PABP, and RNA. Mammalian Protein binding results in coupled folding of part of the
eIF4G is larger than its yeast counterpart, and has addi- previously unstructured N terminus of eIF4E (amino acid
tional carboxy-terminal residues that bind Mnk protein residues 23–38) to form a “wrist” and a protruding “fist”
kinases and contain a second eIF4A binding site (Figure on the convex surface of eIF4E, and of eIF4G (393–490),
1). eIF4A is an ATP-dependent helicase that, as part which forms a “bracelet” of five helices (with the recogni-
of eIF4F, unwinds the cap-proximal region of mRNA. tion motif in helix 4) that encircles the “wrist.” Kinetic
analyses indicated that the initial binding of eIF4E to theAssociation of eIF4E with eIF4G, which directs the heli-
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Figure 1. Domain Structures of Human and Yeast eIF4G Proteins
The relative positions and the amino acid numbering of binding domains for RNA and various initiation factors are shown.
recognition motif, which occurs with micromolar affinity, access to eIF4E. The suggestion by Gross et al. that
assembly of stable eIF4E/eIF4G ribonucleoprotein com-is followed by a second phase during which eIF4E/eIF4G
cofolding yields a stable high affinity complex (Kd 2–5 plex at the capped end of mRNA can promote multiple
rounds of ribosomal loading onto mRNA raises the ques-nM). In addition to promoting tight binding and slow
dissociation kinetics for the resulting complex, forma- tion of how mRNA initially binds to the mRNA binding
cleft of the 40S subunit and from which nucleotide thetion of the interlocking interface between eIF4E and
eIF4G allosterically induces conformational changes in anticodon of initiator tRNA in the ribosomal preinitiation
complex is able to inspect the mRNA. The work by Grossthe cap binding site of eIF4E that significantly enhance
cap binding. In contrast, binding of eIF4E to the eIF4G et al. strongly advances our understanding of the eIF4E/
cap/eIF4G interaction but also emphasizes that there isrecognition motif peptide does not change eIF4E’s affin-
ity for the cap. The biological importance of the N-ter- still much to be learned concerning the architecture of
eukaryotic initiation complexes and the dynamic struc-minal region of eIF4E that interacts with eIF4G was ap-
parent from mutational analyses in yeast, which showed tural rearrangements that they undergo during initiation.
that its deletion led to a decrease in the ratio of poly-
somes to 80S monosomes and to a reduced growth rate.
Tatyana V. Pestova1,2,*Phosphorylation of 4E-BP at four sites is an ordered
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Medical Centerphosphoacceptor residues in the eIF4E/4E-BP complex
Brooklyn, New York 11203and to suggest the structural basis for regulation of 4E-
2 A.N. Belozersky Institute of Physico-chemicalBPs activity by phosphorylation. Thus, the phosphoac-
Biologyceptor residues point toward acidic patches of eIF4E,
Moscow State Universityand the order of phosphorylation correlates with their
Moscow 119899accessibility (Gross et al., 2003). These conclusions ex-
Russiatend previous suggestions for the structural basis for
changes in affinity for eIF4E caused by phosphorylation
of 4E-BP (Marcotrigiano et al., 1999).
Selected ReadingThis exciting structure of the eIF4E/eIF4G complex
raises many further questions about the mechanism of Gingras, A.-C., Raught, B., and Sonenberg, N. (1999). Annu. Rev.
eukaryotic translation initiation and its regulation. For Biochem. 68, 913–963.
example, formation of a tight long-lived eIF4E/eIF4G Gross, J.D., Moerke, N.J., von der Haar, T., Lugovsky, A.A., Sachs,
complex implies the existence of a mechanism for the A.B., McCarthy, J.E.G., and Wagner, G. (2003). Cell, 115, this is-
sue, 739–750.dissociation of eIF4E from eIF4G so that 4E-BP can gain
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Haghighat, A., and Sonenberg, N. (1997). J. Biol. Chem. 272, 21677– the Urbani isolate (Rota et al., 2003). The observations
21680. that ACE2 specifically binds to S1, supports formation
Hershey, P.E.C., McWhirter, S.M., Gross, J.D., Wagner, G., Alber, of syncytia due to cell fusion mediated by the interaction
T., and Sachs, A.B. (1999). J. Biol. Chem. 274, 21297–21304. with S, and mediates infection of cells otherwise ineffi-
Marcotrigiano, J., Gingras, A.-C., Sonenberg, N., and Burley, S.K. cient for virus replication that can be inhibited by an
(1997). Cell 89, 951–961. anti-ACE2 antibody provide convincing evidence for its
Marcotrigiano, J., Gingras, A.-C., Sonenberg, N., and Burley, S.K. receptor function.
(1999). Mol. Cell 3, 707–716. In a remarkable series of experiments, Li et al. not
Matsuo, H., Li, H., McGuire, A.M., Fletcher, C.M., Gingras, A.-C., only identified the virus receptor, but also demonstrated
Sonenberg, N., and Wagner, G. (1997). Nature Struct. Biol. 4, key characteristics of the membrane fusion process me-717–724.
diated by the ACE2 interaction with S. First, they showed
Scheper, G.C., and Proud, C.G. (2002). Eur. J. Biochem. 269, 5350–
that expression of recombinant ACE2 and S resulted in5359.
cell fusion at neutral pH. This finding suggests that low
Ptushkina, M., von der Haar, T., Vasilescu, S., Frank, R., Birkenha¨ger,
pH and other viral proteins are not required for fusion.R., and McCarthy, J.E.G. (1998). EMBO J. 17, 4798–4808.
The S glycoprotein from another SARS-CoV isolatevon der Haar, T., Ball, P.D., and McCarthy, J.E.G. (2000). J. Biol.
(Tor2) can also mediate fusion at neutral pH (Xiao et al.,Chem. 275, 30551–30555.
2003), suggesting that the absence of a low pH require-
ment to trigger fusion is not strain-specific, although
more isolates should be tested. It has also been demon-
strated that expression of recombinant S from some
coronaviruses can lead to syncytia formation at neutral
The Secret Life of ACE2 pH (Lai and Cavanagh, 1997). However, it remains possi-
ble that low pH is important for uptake of cell-free virus.as a Receptor for the SARS Virus
Second, the S glycoprotein was not cleaved to any mea-
surable degree, but effects of cleavage at the cell sur-
face by proteases on fusion cannot be excluded. Recent
biochemical and functional data showed that coronavi-The membrane-associated carboxypeptidase angio-
rus S glycoprotein is a class I fusion protein (Bosch ettensin-converting enzyme 2 (ACE2) is an essential reg-
al., 2003); the lack of cleavage sets apart the SARS-CoVulator of heart function. Now, Li at al. identify and
S glycoprotein and spike proteins from other coronavi-characterize an unexpected second function of ACE2
ruses from a prototype class I fusion protein, which isas a partner of the SARS-CoV spike glycoprotein in
cleaved. Third, the receptor binding domain (RBD) ismediating virus entry and cell fusion.
within the N-terminal fragment containing amino acid
(aa) residues 12–672, which Li et al. define as S1. TheMany cell surface-associated molecules with diverse
RBD was recently localized between residues 303 andsequences, structures, and cellular functions are usurped
537 (Xiao et al., 2003) and is therefore similar to the RBD
by viruses for use as their receptors. Receptor identifica-
of the HCoV-229E, which is within a fragment containing
tion is important for understanding virus tropism, patho-
residues 407 to 547 (Breslin et al., 2003); whether this
genicity, and mechanisms of entry, and may help in the
reflects any similarity in structure and mechanism of
development of therapeutics and vaccines, but remains binding of these human coronaviruses is unknown. Fi-
a challenging task. Although the number of identified nally, Li et al. developed a fusion assay based on syncy-
receptors for human viruses has increased rapidly over tia formation that can be used to study mechanisms
the past two decades, the receptors for most of the and to test inhibitors without the need to work with a
several hundred known human viruses remain elusive. lethal virus. A pseudovirus-based assay would be a use-
The receptor for one of the three known human coronavi- ful complement to control for differences between cell
ruses, HCoV-229E, was identified as the human amino- fusion and virus entry.
peptidase N (hAPN, CD13) more than a decade ago Preliminary experiments reported by Li et al. also give
(Yeager et al., 1992), but the functional receptor for an- some initial clues to the molecular mechanism of the
other human coronavirus, HCoV-OC43, remains un- ACE2 interaction with S. Two mutations of the ACE2
known. However, the overall pace of research on the catalytic site did not affect syncytia formation, indicating
third human coronavirus, the SARS-CoV, has been that the S binding site on ACE2 is located in a different
amazingly rapid, and, in keeping with this, just months region and that the enzymatic function of ACE2 is not
after the virus itself was discovered, the angiotensin- required for fusion. Although normal cellular function is
converting enzyme 2 (ACE2) was identified as its recep- not usually required for a virus receptor function, further
tor (Li et al., 2003). experiments are needed to validate this finding; one
Li et al. used a straightforward approach—coimmuno- possible reason for the lack of effect is related to the long
precipitation of the virus attachment glycoprotein (S1) time (48 hr) of syncytia formation (see the supplementary
with lysates from cells that are susceptible to virus infec- information to Li et al.), which could lead to saturation.
tion (Vero E6) followed by mass spectrometry analysis The fact that the ACE2-S1 association endured the perils
of the coimmunoprecipitated proteins. To express the of the coimmunoprecipitation procedure also suggests
SARS-CoV full-length glycoprotein (S) and S1 in suffi- it may be a high-affinity interaction. The precise affinities
cient amounts required for coimmunoprecipitation and of other coronavirus spike-receptor interactions have
functional characterization, they synthesized a codon- not been determined (Gallagher and Buchmeier, 2001).
However, for most known virus-receptor interactionsoptimized gene based on the published sequence of
